Oriflame
ORIF
position
long
William von Mueffling
Thesis
Oriflame, a cosmetics manufacturer, is currently undervalued as its share price has not increased since its IPO in 2006, despite growth in sales and profits. The company faces challenges due to its exposure to the Russian market and currency mismatches, but its long-term operating history suggests potential for recovery and value appreciation.
Did it work?
Not analyzed yet — run analysis from the issue page.
Raw excerpt
No raw excerpt stored.